Tulane Home Tulane Home
Subscribe to NIH Grants feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 18 hours 25 min ago

Accelerating Data and Metadata Standards in the Environmental Health Sciences (R24 Clinical Trial Not Allowed)

Wed, 01/11/2023 - 02:48
Funding Opportunity RFA-ES-23-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support resource projects to enable Environmental Health Sciences (EHS) communities to openly develop, extend, adapt, or refine data and metadata standards as well as associated tools to implement standards. The initiative is intended to catalyze community-driven standards development and related implementation in environmental health. Projects can support activities at any point in the data standards lifecycle and should build on existing resources, infrastructure, and partnerships whenever possible. The standards, software, best practices, or other tools developed should be broadly disseminated for adoption by the relevant biomedical communities.

Notice of Change in Application Due Date for RFA-EB-21-001

Wed, 01/11/2023 - 02:38
Notice NOT-EB-22-016 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Administrative Supplement to Support Global Cancer Stigma Research

Wed, 01/11/2023 - 02:29
Notice NOT-CA-23-036 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology

Tue, 01/10/2023 - 11:39
Notice NOT-CA-23-030 from the NIH Guide for Grants and Contracts

Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)

Tue, 01/10/2023 - 09:45
Funding Opportunity PAR-23-082 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that employ integrative experimental and analytical approaches engaging basic and translational/clinical research aimed at developing a comprehensive understanding of the impact of sex differences on the trajectories of brain aging and disease, phenotypes of AD and AD-related dementias (ADRD) risk, individualized prevention, and responsiveness to pharmacologic and non-pharmacologic interventions. To this end, the central goal of this initiative is to develop robust research programs that will explore how genes, environment, and host factors such as hormonal status (gonadal and brain-derived) interact at various levels of biologic complexity (i.e., cell, tissue, organs/organ systems, and populations) to produce heterogeneous phenotypes of disease risk and responsiveness to prevention/therapy in AD/ADRD.

NIDA Program Project Grant Applications (P01 Clinical Trial Optional)

Tue, 01/10/2023 - 09:33
Funding Opportunity PAR-23-064 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) announces the availability of support for collaborative research by multi-disciplinary teams which is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches. The NIDA Program Projects funding opportunity will support research in which the funding of three or more highly meritorious projects as a group enriches both the component projects and the overall program to offer significant scientific advantages over supporting the same projects as individual research grants (i.e., synergy). For the duration of the award, each Program must consist of a minimum of three research projects focused on issues critical to advance the mission and goals of NIDA.

Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)

Tue, 01/10/2023 - 09:00
Funding Opportunity PAR-23-062 from the NIH Guide for Grants and Contracts. This FOA solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches, and intervention efficacy or effectiveness trials. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.

Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)

Tue, 01/10/2023 - 08:52
Funding Opportunity PAR-23-061 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.

Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)

Tue, 01/10/2023 - 08:48
Funding Opportunity PAR-23-060 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment. For the purposes of this FOA, intervention is defined to include behavioral, social, or structural approaches, as well as combination biomedical and behavioral, social, or structural approaches that prevent acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected, or both.

Limited Competition: Pediatric Heart Network for the Data Coordinating Center (U24 Clinical Trial Not Allowed)

Tue, 01/10/2023 - 04:10
Funding Opportunity RFA-HL-24-002 from the NIH Guide for Grants and Contracts. This limited competition Funding Opportunity Announcement (FOA)is to support the Data Coordinating Center (DCC) for the Pediatric Heart Network (https://www.pediatricheartnetwork.org/). Only the current Pediatric Heart Network (PHN) DCC awardee is eligible to apply in response to this FOA. The DCC and the Clinical Research Centers (CRCs; see companion FOA RFA-HL-24-001)) will support and conduct research to improve the health and quality of life for children and adults with congenital heart disease, and children with acquired heart disease through multi-center collaborative clinical research. Collaboration among the CRCs, the DCC, and other stakeholders is expected to facilitate multi-center evaluation of medical, interventional, and surgical therapies; support development of novel treatment techniques and methodologies; identify and attempt to address equity gaps in outcomes; provide a training platform for fellows, junior faculty, and nurses; and promote dissemination and implementation of study results to improve the scientific basis for the care of affected individuals.

Pediatric Heart Network Clinical Research Centers (UM1 Clinical Trial Optional)

Tue, 01/10/2023 - 04:07
Funding Opportunity RFA-HL-24-001 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to invite applications to participate as a Clinical Research Center (CRC) in the Pediatric Heart Network (https://www.pediatricheartnetwork.org/). CRCs will be expected to support and conduct research to improve the health and quality of life for children and adults with congenital heart disease and children with acquired heart disease through multi-center collaborative clinical research. Collaboration among the CRCs, the Data Coordinating Center (DCC; see companion FOA RFA-HL-24-002, U24 Resource-Related Research Project (Cooperative Agreements), and other stakeholders is expected to facilitate multi-center evaluation of medical, interventional and surgical therapies; support development of novel treatment techniques and methodologies; identify and attempt to address equity gaps in outcomes; provide a training platform for fellows, junior faculty, and nurses; and promote dissemination and implementation of study results to improve the scientific basis for the care of affected individuals.

Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed)

Tue, 01/10/2023 - 04:00
Funding Opportunity RFA-DE-23-014 from the NIH Guide for Grants and Contracts. To support planning Grant applications that conceptualize the design and implementation of a future national, interdisciplinary, patient-centered research collaborative that will advance Temporomandibular Disorders (TMDs) basic and clinical research, research training, and translation to evidence-based treatments and improved clinical care. These planning grants are intended to enable the institutions to develop the necessary partnerships, infrastructure, and capabilities needed to address the major goals of the future collaborative, develop collaborative -wide research framework and strategies, and coordinate among studies, research projects, and sites, and thereby enhance competitiveness for future participation in TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT).

Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed)

Tue, 01/10/2023 - 03:45
Funding Opportunity RFA-AG-24-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invitesapplications utilizing a cooperative agreement (U24) mechanism to implement a Data Coordinating Center (DCC) that will provide data storage, analysis tools, data analyses, and sharing of data generated by the Interventions Testing Program (ITP), and will develop a publicly accessible and interactive website.

Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed)

Tue, 01/10/2023 - 03:40
Funding Opportunity RFA-AG-24-002 from the NIH Guide for Grants and Contracts. This FOA is for the renewal and further development of the Interventions Testing Program (ITP). The ITP tests, under standardized conditions, potential intervention strategies which may delay aging in mammals. The effect on aging is measured by lifespan extension and/or delayed onset/severity of late life pathologies that can be attributed to the intervention. The ITP uses lifespan as a primary outcome. Secondary outcomes currently include geropathology assessment at old ages and pathology at time of death, functional phenotypes (e.g. measures of strength) and measurements of animal vitals at intervals across the lifespan.

Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)

Tue, 01/10/2023 - 03:29
Funding Opportunity RFA-HL-24-004 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this National Heart, Lung, and Blood Institute (NHLBI) R25 program is to support mentoring and research education activities that enhance the diversity of the biomedical, behavioral and clinical research workforce. The major goal of this R25 program is to establish long-term mentoring that will enable junior faculty who are underrepresented in the biomedical sciences as defined by NOT-OD-20-031, to develop a research program and obtain NIH funding. This FOA specifically invites applications from senior faculty, established researchers, and experienced mentors to develop and direct the Summer Institutes of the Programs for Inclusion and Diversity among Individuals Engaged in Health-Related Research (PRIDE) program in order to mentor promising eligible junior faculty who have specific scientific interests in heart, lung, blood and sleep (HLBS) disorders research. To accomplish the stated overarching goal, this FOA will support creative educational activities with a primary focus on Research Experiences and Mentoring Activities. Success of the PRIDE Summer Institute program will be evaluated using the following metrics: aggregate number and demographic characteristics of participants; career progress of participants, including participation in independent research, employment and promotion in a research or research-related field; authorship of scientific publications in a STEM field; and independent research grant support from NIH or another source subsequent to participation in the PRIDE Summer Institute program.

Pages